Published in J Cell Biol on June 29, 1998
The role of vascular endothelial growth factor in wound healing. J Surg Res (2008) 2.68
Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development. Genes Dev (2006) 2.56
Contact-inhibited chemotaxis in de novo and sprouting blood-vessel growth. PLoS Comput Biol (2008) 2.33
Vascular endothelial growth factor localization in the adult. Am J Pathol (2006) 2.20
Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A (2004) 1.98
Modeling the early stages of vascular network assembly. EMBO J (2003) 1.78
Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biol Ther (2008) 1.77
FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network. Development (2007) 1.67
Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol (2008) 1.56
FGF-dependent regulation of VEGF receptor 2 expression in mice. J Clin Invest (2011) 1.56
The role of fibroblast growth factors in tumor growth. Curr Cancer Drug Targets (2009) 1.52
Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med (2006) 1.49
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci U S A (1999) 1.49
VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci U S A (2006) 1.40
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci U S A (2003) 1.32
FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Dev Biol (2007) 1.26
PPARalpha deficiency in inflammatory cells suppresses tumor growth. PLoS One (2007) 1.24
Retracted Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest (2002) 1.24
Non-thermal dielectric barrier discharge plasma induces angiogenesis through reactive oxygen species. J R Soc Interface (2011) 1.24
Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration. J Cell Biol (2001) 1.22
Shared circuitry: developmental signaling cascades regulate both embryonic and adult coronary vasculature. Circ Res (2009) 1.20
Activation of the VEGFR1 chromatin domain: an angiogenic signal-ETS1/HIF-2alpha regulatory axis. J Biol Chem (2008) 1.20
Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol (2009) 1.19
Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer. Cancer Res (2011) 1.18
The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis. Proc Natl Acad Sci U S A (2004) 1.15
Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. World J Gastroenterol (2003) 1.15
Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. J Biol Chem (2009) 1.14
MicroRNAs-role in lung cancer. Dis Markers (2014) 1.11
Chemotherapeutic drugs and human tumor cells cytokine network. Int J Cancer (2008) 1.11
Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. Am J Pathol (2007) 1.10
Diverse roles of the vasculature within the neural stem cell niche. Regen Med (2009) 1.09
Perlecan and tumor angiogenesis. J Histochem Cytochem (2003) 1.09
Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling. J Clin Invest (2014) 1.08
Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. Proc Natl Acad Sci U S A (2010) 1.07
AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR. J Cell Mol Med (2012) 1.06
Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol (2013) 1.05
Phenotypic and gene expression modification with normal brain aging in GFAP-positive astrocytes and neural stem cells. Aging Cell (2011) 1.04
A homeobox gene related to Drosophila distal-less promotes ovarian tumorigenicity by inducing expression of vascular endothelial growth factor and fibroblast growth factor-2. Am J Pathol (2007) 1.03
Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization. Am J Pathol (2009) 1.03
TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells. Br J Cancer (2006) 1.03
Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis. Proc Natl Acad Sci U S A (2011) 1.02
Roles of FGF signaling in stem cell self-renewal, senescence and aging. Aging (Albany NY) (2011) 1.02
Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells. Angiogenesis (2007) 1.01
In vitro inhibition of angiogenesis by antibodies directed against the 37kDa/67kDa laminin receptor. PLoS One (2013) 0.99
Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer. Br J Cancer (2001) 0.99
Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb. J Appl Physiol (1985) (2002) 0.97
G3139, an anti-Bcl-2 antisense oligomer that binds heparin-binding growth factors and collagen I, alters in vitro endothelial cell growth and tubular morphogenesis. Clin Cancer Res (2009) 0.96
An engineered muscle flap for reconstruction of large soft tissue defects. Proc Natl Acad Sci U S A (2014) 0.95
Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients. Br J Cancer (2003) 0.95
CD44 in rheumatoid arthritis. Arthritis Res Ther (2003) 0.95
Fibroblasts influence muscle progenitor differentiation and alignment in contact independent and dependent manners in organized co-culture devices. Biomed Microdevices (2013) 0.95
Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis. Graefes Arch Clin Exp Ophthalmol (2009) 0.94
Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation. Nat Cell Biol (2014) 0.94
Optical mapping of impulse propagation in engineered cardiac tissue. Tissue Eng Part A (2009) 0.93
Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668. Am J Pathol (2002) 0.93
Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease. Pediatr Nephrol (2013) 0.93
Angiogenesis-related pathways in the pathogenesis of ovarian cancer. Int J Mol Sci (2013) 0.93
Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. Proc Natl Acad Sci U S A (2014) 0.92
Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo. PLoS One (2011) 0.90
Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1. Am J Pathol (1999) 0.90
TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α. Mol Cancer Res (2012) 0.90
Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer. Cancer (2011) 0.90
MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts. Protein Pept Lett (2012) 0.89
Human urine-derived stem cells alone or genetically-modified with FGF2 Improve type 2 diabetic erectile dysfunction in a rat model. PLoS One (2014) 0.89
Embryonic vasculogenesis and hematopoietic specification. Organogenesis (2008) 0.89
Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor. Am J Pathol (1998) 0.89
Possible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathy. Int J Mol Med (2012) 0.89
The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts. Br J Cancer (2000) 0.88
Spatiotemporal tracking of cells in tissue-engineered cardiac organoids. J Tissue Eng Regen Med (2009) 0.88
A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor. J Clin Invest (2003) 0.88
Involvement of metalloprotease-2 in the development of human brain microvessels. Histochem Cell Biol (2004) 0.88
Rebuilding the coronary vasculature: hedgehog as a new candidate for pharmacologic revascularization. Trends Cardiovasc Med (2007) 0.87
Temporally expressed PDGF and FGF-2 regulate embryonic coronary artery formation and growth. Arterioscler Thromb Vasc Biol (2008) 0.87
An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis. J Cell Biol (2006) 0.86
S100A13 is a new angiogenic marker in human melanoma. Mod Pathol (2010) 0.86
Angiogenic synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in an in vitro quantitative microcarrier-based three-dimensional fibrin angiogenesis system. World J Gastroenterol (2004) 0.86
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma. BMC Vet Res (2015) 0.85
DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling. Nat Commun (2012) 0.85
Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor. J Clin Invest (2000) 0.84
Angiogenic therapy for cardiac repair based on protein delivery systems. Heart Fail Rev (2012) 0.83
High-throughput screening for bioactive molecules using primary cell culture of transgenic zebrafish embryos. Cell Rep (2012) 0.83
The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets. Biosci Rep (2014) 0.83
Application of bladder acellular matrix in urinary bladder regeneration: the state of the art and future directions. Biomed Res Int (2015) 0.83
VEGF expression is developmentally regulated during human brain angiogenesis. Histochem Cell Biol (2003) 0.82
TGF-beta1 induces rearrangement of FLK-1-VE-cadherin-beta-catenin complex at the adherens junction through VEGF-mediated signaling. J Cell Biochem (2008) 0.82
Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery. Biomaterials (2014) 0.82
Biofabrication enables efficient interrogation and optimization of sequential culture of endothelial cells, fibroblasts and cardiomyocytes for formation of vascular cords in cardiac tissue engineering. Biofabrication (2012) 0.82
VEGF Trap(R1R2) suppresses experimental corneal angiogenesis. Eur J Ophthalmol (2010) 0.81
Phase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid tumors. Cancer Chemother Pharmacol (2010) 0.81
FGF signaling preserves the integrity of endothelial adherens junctions. Dev Cell (2008) 0.80
Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. Biomaterials (2015) 0.80
Junctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing. PLoS One (2013) 0.79
Novel diabetic mouse models as tools for investigating diabetic retinopathy. PLoS One (2012) 0.79
Bone morphogenetic protein-2/-4 upregulation promoted by endothelial cells in coculture enhances mouse embryoid body differentiation. Stem Cells Dev (2013) 0.79
An integrated approach to quantitative modelling in angiogenesis research. J R Soc Interface (2015) 0.79
Angiogenic Potential of Cryopreserved Amniotic Membrane Is Enhanced Through Retention of All Tissue Components in Their Native State. Adv Wound Care (New Rochelle) (2015) 0.79
[Antiangiogenic treatment for neovascular glaucoma and after filtering surgery]. Ophthalmologe (2009) 0.79
Effect of Local Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Subcutaneously Allotransplanted Ovarian Tissue in Ovariectomized Mice. PLoS One (2015) 0.78
PKCε activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting. J Mol Cell Cardiol (2013) 0.78
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (1996) 18.47
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (1992) 18.26
Mechanisms of angiogenesis. Nature (1997) 18.04
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med (1986) 17.64
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (1996) 16.92
Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (1989) 16.71
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (1993) 15.70
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (1983) 15.43
Angiogenic factors. Science (1987) 15.22
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol (1996) 15.20
Transcriptional activation by tetracyclines in mammalian cells. Science (1995) 13.90
The biology of vascular endothelial growth factor. Endocr Rev (1997) 13.70
What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol (1995) 10.61
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (1992) 10.10
Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (1989) 8.10
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med (1995) 7.88
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem (1991) 7.22
Long-term culture of capillary endothelial cells. Proc Natl Acad Sci U S A (1979) 5.70
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol (1991) 5.61
Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev (1992) 5.50
The role of angiogenesis in tumor growth. Semin Cancer Biol (1992) 5.33
Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem (1995) 5.20
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (1994) 5.19
Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science (1986) 5.12
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem (1992) 4.92
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci (1995) 4.83
Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A (1987) 4.83
Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res (1995) 4.55
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell (1993) 4.33
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet (1996) 4.32
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet (1992) 4.10
Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev (1993) 3.96
Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science (1989) 3.83
The FGF family of growth factors and oncogenes. Adv Cancer Res (1992) 3.83
Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet (1992) 3.77
A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol (1988) 3.72
Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem (1994) 3.68
Biological roles of fibroblast growth factor-2. Endocr Rev (1997) 3.57
Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest (1995) 3.52
High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci U S A (1989) 3.45
FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J (1991) 3.19
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest (1994) 3.11
High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol (1987) 3.10
Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J (1990) 3.10
Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc Natl Acad Sci U S A (1989) 3.00
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res (1993) 2.98
Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer (1996) 2.96
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem (1994) 2.87
Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A (1998) 2.78
Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol (1988) 2.69
Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. Proc Natl Acad Sci U S A (1986) 2.62
Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry (1989) 2.49
Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci U S A (1991) 2.48
Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol (1991) 2.47
Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun (1992) 2.47
Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res (1995) 2.34
Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med (1995) 2.29
Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer (1994) 2.24
Fibroblast growth factor 2 control of vascular tone. Nat Med (1998) 2.21
Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation (1995) 2.18
Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J (1989) 2.14
VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem (1997) 2.12
Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest (1994) 2.10
Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol (1992) 2.08
Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation (1994) 2.08
Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell (1993) 1.97
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (1995) 1.92
Both normal and tumor cells produce basic fibroblast growth factor. J Cell Physiol (1986) 1.91
Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res (1996) 1.86
Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem (1996) 1.81
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med (1995) 1.78
Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res (1994) 1.75
Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol (1990) 1.75
Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem (1995) 1.71
Expression of basic fibroblast growth factor in normal human tissues. Lab Invest (1990) 1.70
A form of human basic fibroblast growth factor with an extended amino terminus. Biochem Biophys Res Commun (1987) 1.69
Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science (1989) 1.68
Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest (1996) 1.63
Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol (1992) 1.60
Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci U S A (1991) 1.52
Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol (1994) 1.52
Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem (1997) 1.44
Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol (1989) 1.42
Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor. Proc Natl Acad Sci U S A (1987) 1.39
Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci (1997) 1.38
Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg (1995) 1.33
Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell (1993) 1.31
In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol (1990) 1.31
Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms. J Cell Biol (1995) 1.30
Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors (1991) 1.29
The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol (1991) 1.29
Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol (1994) 1.24
Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution. Mol Biol Cell (1996) 1.12
Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol (1996) 1.11
Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem (1995) 1.09
Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. In Vivo (1995) 1.08
Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells. Cell Regul (1991) 1.07
Angiogenesis in embryos and ischemic diseases. Thromb Haemost (1997) 1.05
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell (1999) 11.59
Polarized monolayers formed by epithelial cells on a permeable and translucent support. J Cell Biol (1978) 7.69
Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40
An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem (1994) 6.31
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sex Transm Infect (2003) 5.26
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med (1973) 4.99
Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol (1989) 4.57
Biology and biochemistry of proteinases in tumor invasion. Physiol Rev (1993) 4.17
The natural history of asthma in childhood. J Epidemiol Community Health (1986) 4.09
2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor. Bioorg Med Chem Lett (2000) 4.03
Human herpesvirus 8 variants in sarcoid tissues. Lancet (1997) 3.87
Biological roles of fibroblast growth factor-2. Endocr Rev (1997) 3.57
Comparison of percutaneous and surgical tracheostomies. Chest (1996) 3.56
Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A (1999) 3.42
Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell (1986) 3.42
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med (1999) 3.39
Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol (2001) 3.38
Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol (1988) 3.16
Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol (2001) 3.09
Math5 is required for retinal ganglion cell and optic nerve formation. Development (2001) 3.07
Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature (1995) 3.06
BRCA2 mutations in primary breast and ovarian cancers. Nat Genet (1996) 2.91
Treatment of AIDS-related bronchopleural fistula by pleurectomy. Ann Thorac Surg (1992) 2.88
Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol (1988) 2.84
Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int (1997) 2.82
Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol (1988) 2.69
Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol (1990) 2.65
Identification of the major intestinal fatty acid transport protein. Mol Cell (1999) 2.65
Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. Proc Natl Acad Sci U S A (1986) 2.62
Screening and optimization strategies for macromolecular crystal growth. Acta Crystallogr D Biol Crystallogr (1994) 2.62
Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Diabetes Obes Metab (2011) 2.59
The Revival of Organisms Presumably Killed by Phenol. J Bacteriol (1945) 2.58
A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity (1998) 2.56
The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem (1999) 2.45
Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg (2001) 2.44
Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut (1989) 2.44
A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci U S A (1985) 2.38
Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet (1994) 2.35
Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol (1990) 2.33
Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol (1982) 2.33
Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A (1991) 2.27
Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1. Mol Biol Cell (1998) 2.26
Stage-specific surface antigens expressed during the morphogenesis of vertebrate forms of Trypanosoma cruzi. Exp Parasitol (1987) 2.25
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22
Experience in third molar surgery: an update. Br Dent J (2010) 2.22
Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells. Cell Death Differ (2010) 2.17
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke (1999) 2.17
Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol (1992) 2.08
In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol (1989) 2.05
The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol (1987) 2.04
Fundamental training. Br Dent J (2009) 2.03
Does examination of urinary sediment identify individuals with Gulf War syndrome? A pilot study. Am J Med Sci (1998) 2.03
Surgical treatment for aneurysm of aberrant subclavian artery based on a case report and a review of the literature. J Thorac Cardiovasc Surg (1988) 2.03
Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol (1997) 1.98
Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol. J Biol Chem (1988) 1.98
The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesth Analg (1996) 1.97
Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. Clin Exp Immunol (1988) 1.95
Current outcome of antenally diagnosed cystic lung disease. J Pediatr Surg (2004) 1.95
Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol (1986) 1.94
TGF-beta latency: biological significance and mechanisms of activation. Stem Cells (1997) 1.91
Both normal and tumor cells produce basic fibroblast growth factor. J Cell Physiol (1986) 1.91
The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans. J Antimicrob Chemother (1991) 1.90
Transformation of rat embryo fibroblasts by cloned polyoma virus DNA fragments containing only part of the early region. Proc Natl Acad Sci U S A (1980) 1.89
Properties of plasminogen activators formed by neoplastic human cell cultures. J Exp Med (1974) 1.88
Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol (2001) 1.88
Participation of plasma membrane proteins in the formation of tight junctions by cultured epithelial cells. J Cell Biol (1983) 1.87
Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization. N Engl J Med (1965) 1.87
Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol (2001) 1.86
Infectious agents are not necessary for murine atherogenesis. J Exp Med (2000) 1.85
Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J (1997) 1.85
Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain (2000) 1.83
Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta (1988) 1.82
Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med (1990) 1.80
Mitochondrial DNA sequence diversity in bipolar affective disorder. Am J Psychiatry (2000) 1.77
Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study. Cancer (1999) 1.77
Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy. Clin Cancer Res (2001) 1.76
The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain (2001) 1.76
Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol (1990) 1.75
National survey of stress ulcer prophylaxis. Crit Care Med (1999) 1.72
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J Cell Biol (1993) 1.71
Group C Niemann-Pick disease: faulty regulation of low-density lipoprotein uptake and cholesterol storage in cultured fibroblasts. FASEB J (1987) 1.71
Respiratory morbidity and lung function after whooping-cough. Lancet (1983) 1.71
Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol (1988) 1.69
Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg (1991) 1.69
Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut (2008) 1.69
A form of human basic fibroblast growth factor with an extended amino terminus. Biochem Biophys Res Commun (1987) 1.69
Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J (1974) 1.69
Proteolytically derived fragments of human plasma fibronectin and their localization within the intact molecule. J Biol Chem (1980) 1.68
In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc Natl Acad Sci U S A (2000) 1.67
Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem (2001) 1.67
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol (1993) 1.66
hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer (2003) 1.65
The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments. J Exp Med (1990) 1.64
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry (2012) 1.63
Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ (2003) 1.60
Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res (1990) 1.59